They observed partial activation of the normally silent maternal genes such as SNORD116 in both mouse and human fibroblasts PWS models and demonstrated improved survival and growth compared to the untreated when administered by intraperitoneal injection into PWS mice. This evidence concerns the gene SNORD116 and Prader-Willi syndrome.